India's Plethico Pharmaceutical Ltd, a global healthcare company, is to invest $20 million in a new manufacturing facility in Kenya.The new facility will target the East and Central African market and is expected start operations by the end of this year.
The company intends to manufacture a wide range of pharmaceutical products, notably antibiotics, anti-tubercular, anti-malarial, cardiovascular, anti-diarrhoeal, analgesics, muscle relaxants, ARVs, cough and cold preparations.
